Press Releases

12 Jun 2025

Repurposed cancer drugs found to promote stroke recovery, limit brain damage

A recent study by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has shown that a class of drugs, HDACi (histone deacetylase inhibitors), protects neurons and limits brain damage following stroke by altering the gene expression of microglia, the immune cells of the brain. HDACi are currently used or being tested as treatments for certain cancers and are also being researched for neurological conditions such as Alzheimer’s disease.

11 Jun 2025

AI designs drug combinations specifically for women or men to optimise heart valve disease treatment

09 Jun 2025

NUS Medicine researchers develop a better and more accurate biological ageing clock

Researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) have developed an improved biological ageing clock, LinAge2, that offers doctors a practical and more accurate way to assess how quickly a person is ageing, and what can be done to slow it down.

03 Jun 2025

Endocrinologists asked to step up efforts to reduce carbon footprint of healthcare

A new international review led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has highlighted the often-overlooked environmental impact of healthcare, especially in endocrinology.

27 May 2025

NUS Medicine and IHME joint Lancet Publications

Singapore has achieved exceptional public health successes while confronting emerging challenges, according to a series of four new studies published in the Lancet Public Health. Jointly led by the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and the Institute for Health Metrics and Evaluation (IHME), University of Washington School of Medicine, this special series is the first of its kind research focused on injuries, cardiovascular disease (CVD), smoking prevalence, and mental health burden in the ASEAN region. “The findings present a nuanced picture of Singapore’s health progress. While we’ve made remarkable strides in areas like cardiovascular care and tobacco control, the growing burden of mental health conditions and injuries, particularly self-harm and falls, calls for urgent and sustained attention,” said lead author Dr Marie Ng, Associate Professor, NUS Medicine, and Affiliate Associate Professor at IHME.

08 May 2025

Professor Shawn Chen appointed founding Editor-in-Chief of newly launched ACS Nano Medicine

Professor Xiaoyuan (Shawn) Chen, Nasrat Muzayyin Chair Professor in Medicine and Technology, Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), has been appointed the founding Editor-in-Chief of ACS Nano Medicine, a new peer-reviewed hybrid journal published by the American Chemical Society (ACS).

07 May 2025

Flagship Pioneering, the National University of Singapore, National University Hospital and the National University Health System Announce Collaboration to Advance Biotech Research & Development

Flagship Pioneering, the bioplatform innovation company, the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), National University Hospital (NUH) and the National University Health System (NUHS) today announced a research and development collaboration to advance outcomes in human health and sustainability. Flagship, NUS Medicine, NUH and NUHS outlined the goals of their collaboration via a Memorandum of Understanding (MOU) signed this week.

06 May 2025

Study findings support the use of a personalised medicine approach to treat Soft Tissue Sarcomas

A study conducted by researchers from the Agency for Science, Technology and Research (A*STAR), National Cancer Centre Singapore (NCCS) and National University of Singapore (NUS), in collaboration with biotech company, KYAN Technologies, has demonstrated that a precision medicine approach improves treatment selection for patients with soft tissue sarcomas (STS) in a clinical setting.

30 Apr 2025

Heinz College announces collaboration with the National University of Singapore and FriendsLearn to promote research & development activities on digital therapeutics

The Heinz College of Information Systems and Public Policy will work with the National University of Singapore (NUS) Yong Loo Lin School of Medicine (NUS Medicine) and School of Computing (NUS Computing), and with the firm FriendsLearn, to promote joint research and development activities of mutual interest. The research will use artificial intelligence (AI) in precision prevention of disease via innovative digital therapeutic solutions such as digital vaccines.

25 Apr 2025

World Sleep Society recommendations on wearable sleep trackers aim to empower consumers and clinicians, and foster industry partnership

Led by Professor Michael Chee, Director of the Centre for Sleep and Cognition at Yong Loo Lin School of Medicine (NUS Medicine), an international team of sleep experts from the US, Australia, Europe and Singapore, took into consideration, industry input, critique from clinicians and previous position papers to develop recommendations that provide clear and practical points for consumers, clinicians, researchers, and manufacturers, to tap the potential of wearable consumer health trackers (CHTs) in an evidence-guided manner. Used regularly, CHTs serve as a "sleep minder," offering a continuous diary of sleep habits, providing insights into sleep patterns over extended periods on a scale previously not possible. However, the accuracy of different devices can vary significantly, depending on the quality and/or configuration of their sensors, and the algorithms used to interpret the data. These new recommendations will enable people make meaningful choices for better sleep and better health.